Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Madrigal Pharmaceuticals, Inc. (MDGL)

518.16 +0.77 (+0.15%)
As of 10:59:38 AM EDT. Market Open.
Trade MDGL on Coinbase
Chart Range Bar
Loading chart for MDGL
  • Previous Close 517.39
  • Open 518.11
  • Bid 515.15 x 100
  • Ask 520.68 x 100
  • Day's Range 504.01 - 520.27
  • 52 Week Range 265.00 - 615.00
  • Volume 45,402
  • Avg. Volume 349,698
  • Market Cap (intraday) 11.946B
  • Beta (5Y Monthly) -1.01
  • PE Ratio (TTM) --
  • EPS (TTM) -12.87
  • Earnings Date May 6, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 672.79

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

www.madrigalpharma.com

915

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview: MDGL

Trailing total returns as of 5/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MDGL
11.02%
S&P 500 (^GSPC)
5.85%

1-Year Return

MDGL
58.12%
S&P 500 (^GSPC)
29.30%

3-Year Return

MDGL
67.48%
S&P 500 (^GSPC)
73.86%

5-Year Return

MDGL
280.72%
S&P 500 (^GSPC)
73.30%

Earnings Trends: MDGL

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 321.08M
Earnings -58.58M

Q1

FY25

Q2

FY25

Q3

FY25

Q4

FY25

-100M
0
100M
200M
300M

Analyst Insights: MDGL

View More

Analyst Price Targets

529.00
672.79 Average
518.16 Current
964.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 2/20/2026
Analyst B of A Securities
Rating Action Maintains
Rating Neutral
Price Action Lowers
Price Target 570 -> 529

Statistics: MDGL

View More

Valuation Measures

Annual
As of 11/13/2025
  • Market Cap

    11.92B

  • Enterprise Value

    11.28B

  • Trailing P/E

    --

  • Forward P/E

    666.67

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    12.10

  • Price/Book (mrq)

    19.77

  • Enterprise Value/Revenue

    11.77

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -30.08%

  • Return on Assets (ttm)

    -16.30%

  • Return on Equity (ttm)

    -42.49%

  • Revenue (ttm)

    958.4M

  • Net Income Avi to Common (ttm)

    -288.28M

  • Diluted EPS (ttm)

    -12.87

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    983.56M

  • Total Debt/Equity (mrq)

    57.68%

  • Levered Free Cash Flow (ttm)

    -115.08M

Compare To: MDGL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights: MDGL

Fair Value

518.16 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports: MDGL

View More
  • Daily – Vickers Top Buyers & Sellers for 01/27/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 01/21/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 01/28/2025

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 01/21/2025

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: